These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Recruitment of podoplanin positive cancer-associated fibroblasts in metastatic lymph nodes predicts poor prognosis in pathological N2 stage III lung adenocarcinoma. Neri S; Ishii G; Taira T; Hishida T; Yoshida J; Nishimura M; Nagai K; Ochiai A Ann Surg Oncol; 2012 Nov; 19(12):3953-62. PubMed ID: 22669451 [TBL] [Abstract][Full Text] [Related]
3. Podoplanin expressing cancer associated fibroblasts are associated with unfavourable prognosis in adenocarcinoma of the esophagus. Schoppmann SF; Jesch B; Riegler MF; Maroske F; Schwameis K; Jomrich G; Birner P Clin Exp Metastasis; 2013 Apr; 30(4):441-6. PubMed ID: 23161183 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of podoplanin expression in oral squamous cell carcinoma--a regression model auxiliary to UICC classification. Seki S; Fujiwara M; Matsuura M; Fujita S; Ikeda H; Umeda M; Asahina I; Ikeda T Pathol Oncol Res; 2014 Jul; 20(3):521-8. PubMed ID: 24281769 [TBL] [Abstract][Full Text] [Related]
5. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma. Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S Oncology; 2009; 77(1):53-62. PubMed ID: 19556810 [TBL] [Abstract][Full Text] [Related]
6. Podoplanin, α-smooth muscle actin or S100A4 expressing cancer-associated fibroblasts are associated with different prognosis in colorectal cancers. Choi SY; Sung R; Lee SJ; Lee TG; Kim N; Yoon SM; Lee EJ; Chae HB; Youn SJ; Park SM J Korean Med Sci; 2013 Sep; 28(9):1293-301. PubMed ID: 24015033 [TBL] [Abstract][Full Text] [Related]
7. Functional invadopodia formation through stabilization of the PDPN transcript by IMP-3 and cancer-stromal crosstalk for PDPN expression. Hwang YS; Xianglan Z; Park KK; Chung WY Carcinogenesis; 2012 Nov; 33(11):2135-46. PubMed ID: 22859271 [TBL] [Abstract][Full Text] [Related]
8. Podoplanin expression during dysplasia-carcinoma sequence in the oral cavity. Inoue H; Miyazaki Y; Kikuchi K; Yoshida N; Ide F; Ohmori Y; Tomomura A; Sakashita H; Kusama K Tumour Biol; 2012 Feb; 33(1):183-94. PubMed ID: 22081310 [TBL] [Abstract][Full Text] [Related]
9. Podoplanin-positive cancer-associated fibroblasts could have prognostic value independent of cancer cell phenotype in stage I lung squamous cell carcinoma: usefulness of combining analysis of both cancer cell phenotype and cancer-associated fibroblast phenotype. Ono S; Ishii G; Nagai K; Takuwa T; Yoshida J; Nishimura M; Hishida T; Aokage K; Fujii S; Ikeda N; Ochiai A Chest; 2013 Apr; 143(4):963-970. PubMed ID: 23081722 [TBL] [Abstract][Full Text] [Related]
11. Concordant podoplanin expression in cancer-associated fibroblasts and tumor cells is an adverse prognostic factor in esophageal squamous cell carcinoma. Chuang WY; Yeh CJ; Chao YK; Liu YH; Chang YS; Tseng CK; Chang HK; Wan YL; Hsueh C Int J Clin Exp Pathol; 2014; 7(8):4847-56. PubMed ID: 25197355 [TBL] [Abstract][Full Text] [Related]
12. Interaction between oral squamous cell carcinoma cells and fibroblasts through TGF-β1 mediated by podoplanin. Li YY; Zhou CX; Gao Y Exp Cell Res; 2018 Aug; 369(1):43-53. PubMed ID: 29719198 [TBL] [Abstract][Full Text] [Related]
13. Podoplanin expression correlates with sentinel lymph node metastasis in early squamous cell carcinomas of the oral cavity and oropharynx. Huber GF; Fritzsche FR; Züllig L; Storz M; Graf N; Haerle SK; Jochum W; Stoeckli SJ; Moch H Int J Cancer; 2011 Sep; 129(6):1404-9. PubMed ID: 21105028 [TBL] [Abstract][Full Text] [Related]
14. Podoplanin expression in cancer-associated fibroblasts predicts unfavorable prognosis in node-negative breast cancer patients with hormone receptor-positive/HER2 - negative subtype. Tanaka Y; Ohno T; Kadonaga T; Kidokoro Y; Wakahara M; Nosaka K; Sakabe T; Suzuki Y; Nakamura H; Umekita Y Breast Cancer; 2021 Jul; 28(4):822-828. PubMed ID: 33481184 [TBL] [Abstract][Full Text] [Related]
15. Expression of podoplanin and prognosis in oropharyngeal cancer. Preuss SF; Anagiotos A; Seuthe IM; Drebber U; Wedemeyer I; Kreppel M; Semrau R; Eslick GD; Klussmann JP; Huebbers CU Eur Arch Otorhinolaryngol; 2015 Jul; 272(7):1749-54. PubMed ID: 24880471 [TBL] [Abstract][Full Text] [Related]
16. Impact of different tumour stroma assessment methods regarding podoplanin expression on clinical outcome in patients with invasive ductal breast carcinoma. Pula B; Wojnar A; Werynska B; Ambicka A; Kruczak A; Witkiewicz W; Ugorski M; Podhorska-Okolow M; Dziegiel P Anticancer Res; 2013 Apr; 33(4):1447-55. PubMed ID: 23564785 [TBL] [Abstract][Full Text] [Related]
17. Diminished CD68 Zhao X; Ding L; Lu Z; Huang X; Jing Y; Yang Y; Chen S; Hu Q; Ni Y Am J Pathol; 2020 Apr; 190(4):886-899. PubMed ID: 32035062 [TBL] [Abstract][Full Text] [Related]
18. Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy. Kawaguchi H; El-Naggar AK; Papadimitrakopoulou V; Ren H; Fan YH; Feng L; Lee JJ; Kim E; Hong WK; Lippman SM; Mao L J Clin Oncol; 2008 Jan; 26(3):354-60. PubMed ID: 18202409 [TBL] [Abstract][Full Text] [Related]
19. Lymphangiogenesis and podoplanin expression in oral squamous cell carcinoma and the associated lymph nodes. de Sousa SF; Gleber-Netto FO; de Oliveira-Neto HH; Batista AC; Nogueira Guimarães Abreu MH; de Aguiar MC Appl Immunohistochem Mol Morphol; 2012 Dec; 20(6):588-94. PubMed ID: 22495364 [TBL] [Abstract][Full Text] [Related]
20. Correlation between podoplanin expression and extracapsular spread in squamous cell carcinoma of the oral cavity using subjective immunoreactivity scores and semiquantitative image analysis. Mermod M; Bongiovanni M; Petrova TV; Dubikovskaya EA; Simon C; Tolstonog G; Monnier Y Head Neck; 2017 Jan; 39(1):98-108. PubMed ID: 27437903 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]